Literature DB >> 3034535

Kaposi's sarcoma of the conjunctiva and CMV-retinitis in AIDS.

O H Visser, P J Bos.   

Abstract

The number of AIDS patients is still increasing. In 30-50% of these patients ocular lesions occur, which are of diagnostic and prognostic significance. If the life-span of AIDS patients lengthens in the future, adequate treatment of the ocular conditions will become increasingly important. The two most important ocular manifestations AIDS are CMV-retinitis and Kaposi's sarcoma of the conjunctiva. DHPG, a new virustatic for human cytomegalovirus, appears promising as treatment for the severe CMV-retinitis, which leads rapidly to blindness. Two case histories illustrate the preliminary results obtained with DHPG treatment. Kaposi's sarcoma of the conjunctiva is relatively benign is AIDS and can be treated successfully by surgical excision, radiotherapy, cryotherapy or local injections of cytostatics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3034535     DOI: 10.1007/BF00166688

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Authors:  S A Plotkin; W L Drew; D Felsenstein; M S Hirsch
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

2.  Ophthalmic involvement in acquired immunodeficiency syndrome.

Authors:  A G Palestine; M M Rodrigues; A M Macher; C C Chan; H C Lane; A S Fauci; H Masur; D Longo; C M Reichert; R Steis
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

3.  Ocular effects in acquired immune deficiency syndrome.

Authors:  J S Schuman; A H Friedman
Journal:  Mt Sinai J Med       Date:  1983 Sep-Oct

4.  The clinical and morphologic characteristics of Kaposi's sarcomas of the conjunctiva.

Authors:  J J Weiter; F A Jakobiec; T Iwamoto
Journal:  Am J Ophthalmol       Date:  1980-04       Impact factor: 5.258

5.  Kaposi's sarcoma of the conjunctiva.

Authors:  E Nicolitz
Journal:  Ann Ophthalmol       Date:  1981-02

6.  Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine.

Authors:  A G Palestine; G Stevens; H C Lane; H Masur; L S Fujikawa; R B Nussenblatt; A H Rook; J Manischewitz; B Baird; M Megill
Journal:  Am J Ophthalmol       Date:  1986-01-15       Impact factor: 5.258

7.  Multicentric Kaposi's sarcoma of the conjunctiva in a male homosexual with the acquired immunodeficiency syndrome.

Authors:  A M Macher; A Palestine; H Masur; G Bryant; C C Chan; R B Nussenblatt; M M Rodrigues
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

8.  Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

Authors:  D Felsenstein; D J D'Amico; M S Hirsch; D A Neumeyer; D M Cederberg; P de Miranda; R T Schooley
Journal:  Ann Intern Med       Date:  1985-09       Impact factor: 25.391

9.  [Kaposi's sarcoma and AIDS].

Authors:  H Reich; F Hollwich; D Uthoff
Journal:  Klin Monbl Augenheilkd       Date:  1985-07       Impact factor: 0.700

  9 in total
  3 in total

Review 1.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 2.  Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.

Authors:  W J Keijer; D M Burger; G H Neuteboom; J L Vrooland; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-04-23

3.  Isolated Bulbar Conjunctival Kaposi's Sarcoma as a Primary Presentation of AIDS: A Case Report.

Authors:  Sofia Maia; Miguel Gomes; Luís Oliveira; Paulo Torres
Journal:  Case Rep Ophthalmol Med       Date:  2013-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.